Back to Search Start Over

Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release.

Authors :
Stewart H
Palmulli R
Johansen KH
McGovern N
Shehata OM
Carnell GW
Jackson HK
Lee JS
Brown JC
Burgoyne T
Heeney JL
Okkenhaug K
Firth AE
Peden AA
Edgar JR
Source :
EMBO reports [EMBO Rep] 2023 Dec 06; Vol. 24 (12), pp. e57224. Date of Electronic Publication: 2023 Oct 11.
Publication Year :
2023

Abstract

The antiviral restriction factor, tetherin, blocks the release of several different families of enveloped viruses, including the Coronaviridae. Tetherin is an interferon-induced protein that forms parallel homodimers between the host cell and viral particles, linking viruses to the surface of infected cells and inhibiting their release. We demonstrate that SARS-CoV-2 infection causes tetherin downregulation and that tetherin depletion from cells enhances SARS-CoV-2 viral titres. We investigate the potential viral proteins involved in abrogating tetherin function and find that SARS-CoV-2 ORF3a reduces tetherin localisation within biosynthetic organelles where Coronaviruses bud, and increases tetherin localisation to late endocytic organelles via reduced retrograde recycling. We also find that expression of Spike protein causes a reduction in cellular tetherin levels. Our results confirm that tetherin acts as a host restriction factor for SARS-CoV-2 and highlight the multiple distinct mechanisms by which SARS-CoV-2 subverts tetherin function.<br /> (© 2023 The Authors. Published under the terms of the CC BY 4.0 license.)

Details

Language :
English
ISSN :
1469-3178
Volume :
24
Issue :
12
Database :
MEDLINE
Journal :
EMBO reports
Publication Type :
Academic Journal
Accession number :
37818801
Full Text :
https://doi.org/10.15252/embr.202357224